The shares of ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) has been pegged with a rating of Buy by Maxim Group in its latest research note that was published on July 10th, 2018. The research company has also assigned a $3 price target. Maxim Group wasn’t the only research firm that published a report of ContraVir Pharmaceuticals, Inc., with other equities research analysts also giving their opinion on the stock. Maxim Group advised investors in its research note published on February 13th, 2018, to Hold the CTRV stock.
Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 1 believe it has the potential for further growth, thus rating it as Hold while 0 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $2.00. The price of the stock the last time has raised by 31.00% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 43.81.
The shares of the company added by 19.09% during the trading session on Thursday, reaching a low of $0.11 while ending the day at $0.13. During the trading session, a total of 11.41 million shares were traded which represents a -260.97% decline from the average session volume which is 3.16M shares. CTRV had ended its last session trading at 0.11. ContraVir Pharmaceuticals, Inc. currently has a market cap of $4.70M, with a beta of 1.28. CTRV 52-week low price stands at $0.10 while its 52-week high price is $2.60.
ContraVir Pharmaceuticals, Inc. has the potential to record -1.38 EPS for the current fiscal year, according to equities analysts.
Investment analysts at Bernstein published a research note on May 21st, 2019 where it informed investors and clients that The Kroger Co. (NYSE:KR) is now rated as Outperform. Their price target on the stock stands at $33. Maxim Group also rated KR as Downgrade on February 13th, 2018, with its price target of $15.50 suggesting that KR could surge by 16.47% from its current share price. Even though the stock has been trading at $24.00/share, analysts expect it to surge higher by -1.96% to reach $28.17/share. It started the day trading at $23.84 and traded between $23.43 and $23.53 throughout the trading session.
A look at its technical shows that KR’s 50-day SMA is 24.86 while its 200-day SMA stands at 28.04. The stock has a high of $32.74 for the year while the low is $23.52. The company’s P/E ratio currently sits at 6.36, while the P/B ratio is 2.38. At the moment, only of The Kroger Co. shares were sold short. The company’s average trading volume currently stands at 9.01M shares, which means that the short-interest ratio is just 3.70 days. Over the past seven days, the company moved, with its shift of -4.58%. Looking further, the stock has dropped -17.50% over the past 90 days while it lost -23.00% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc sold more KR shares, decreasing its portfolio by -0.36% during the last quarter. This move now sees The Vanguard Group Inc selling -243,750 shares in the last quarter, thus it now holds 66,785,703 shares of KR, with a total valuation of $1,721,735,423. BlackRock Fund Advisors meanwhile sold more KR shares in the recently filed quarter, changing its stake to $1,024,750,076 worth of shares. SSgA Funds Management Inc followed the path by increasing its KR portfolio by +8.99% in the quarter. This means that SSgA Funds Management Inc bought 3,259,330 shares in the last quarter and now controls 39,531,207 shares of the KR stock, with the valuation hitting $1,019,114,516.
Similarly, LSV Asset Management increased its The Kroger Co. shares by +1.80% during the recently filed quarter. After buying 361,800 shares in the last quarter, the firm now controls 20,412,468 shares of The Kroger Co. which are valued at $526,233,425. In the same vein, Fidelity Management Research Co decreased its The Kroger Co. shares by during the most recent reported quarter. The firm sold -2,740,424 shares during the quarter which decreased its stakes to 16,752,820 shares and is now valued at $431,887,700. Following these latest developments, around 0.80% of The Kroger Co. stocks are owned by institutional investors and hedge funds.